Preprint Concept Paper Version 1 Preserved in Portico This version is not peer-reviewed

Use of a Polypill to Reduce Cardiovascular Risk Factors in Primary and Secondary Prevention: Review and Use Guidelines

Version 1 : Received: 29 March 2022 / Approved: 31 March 2022 / Online: 31 March 2022 (10:01:28 CEST)

How to cite: Esquirol Caussa, J.; Herrero Vila, E.; Sánchez Aldeguer, J. Use of a Polypill to Reduce Cardiovascular Risk Factors in Primary and Secondary Prevention: Review and Use Guidelines. Preprints 2022, 2022030404 (doi: 10.20944/preprints202203.0404.v1). Esquirol Caussa, J.; Herrero Vila, E.; Sánchez Aldeguer, J. Use of a Polypill to Reduce Cardiovascular Risk Factors in Primary and Secondary Prevention: Review and Use Guidelines. Preprints 2022, 2022030404 (doi: 10.20944/preprints202203.0404.v1).

Abstract

INTRODUCTION: Primary and secondary cardiovascular prevention programs present less efficacy than desired due to the professionals’ lack of adherence when prescribing different drugs to the same patient, and due to patients’ lack of adherence in the medium and long term to medications prescribed. Polypills are considered as a possible solution to these problems. An evidence-based review about a cardiovascular prevention polypill efficacy and a guide for its use is presented.METHODS: Comprehensive bibliographical review of the evidence published on the polypill as a mechanism for facilitating medication adherence in primary and secondary cardiovascular prevention.RESULTS: A total of 31 published articles were included, showing the options of the polypill as a method of primary and secondary cardiovascular prevention. Polypill can increase the therapeutic adherence of patients in the medium and long term, also increasing therapeutic results compared to the administration of the same different drugs separately. Based on the evidence, a flow chart for the prescription of a polypill has been developed.DISCUSSION AND CONCLUSIONS: The use of a polypill increases the effectiveness and adherence of patients to primary and secondary cardiovascular prevention programs, without increasing the cost of the intervention. The use of a polypill in cardiovascular prevention can be effective as a prescription tool.

Keywords

Polypill; Cardiovascular Risk; Primary Prevention; Secondary Prevention; Adherence; Cost-effectivity

Subject

MEDICINE & PHARMACOLOGY, Other

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.